19

2018

-

11

Announcement of the full text of the environmental impact report of the renovation and expansion project

Author:


Announcement on the full text of the environmental impact report of the reconstruction and expansion project of Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd.

According to the relevant provisions of the "Environmental Impact Assessment Law" and the "Interim Measures for Public Participation in Environmental Impact Assessment". Solicit the opinions of individuals and units related to the reconstruction and expansion project of Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd. on the project construction and environmental protection. The general public is kindly requested to participate actively. The full text of the project’s environmental impact report is now publicized. The information is as follows:
  
1. Construction unit and contact information:
  
Construction unit: Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd.
  
Address: No. 108, Jinyuan Avenue South Road, Banxi Industrial Park, Youyang County, Chongqing
  
Contact: Minister Liu
  
Tel: +86-13709496777
  
Email: 273800777@qq.com
  
2. The name and contact information of the environmental impact assessment agency:
  
Unit name: Zhonghuan Lianxin (Beijing) Environmental Protection Co., Ltd.
  
Certificate Number: National Environmental Assessment Certificate No. 1058
  
Address: 3109, Building 5, Shidaitian Street, Longhu District, Yuzhong District, Chongqing
  
Contact: Wu Gong
  
Contact number (fax): +86-023-68075970
  
Email: 283535161@qq.com (please specify the subject of the email: Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd. Reconstruction and Expansion Project Public Opinions)
  
3. How to check the report
  
Welcome the units and individuals concerned about this project to consult the paper version of the "Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd. Environmental Impact Report (public version)" after the announcement.
  
4. solicit opinions
  
The public can provide Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd. or Zhonghuan Lianxin (Beijing) Environmental Protection Co., Ltd. with valuable opinions on the environmental impact of the project and environmental protection measures through e-mail, telephone, fax, etc. The public is requested to provide detailed contact information while expressing their opinions, so that we can promptly feedback relevant information to you.

Previous

Next

Previous

Next

Latest News

2018-11-19

Announcement of the full text of the environmental impact report of the renovation and expansion project

According to the relevant provisions of the "Environmental Impact Assessment Law" and the "Interim Measures for Public Participation in Environmental Impact Assessment".

2018-10-24

The second public announcement of the environmental impact assessment of the reconstruction and expansion project of Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd.

According to the relevant provisions of the "Interim Measures for Public Participation in Environmental Impact Assessment", the relevant information on the environmental impact assessment of the "Reconstruction and Expansion Project of Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd." is now announced.

2018-10-08

Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd. Reconstruction and Expansion Project Environmental Impact Assessment Public Participation First Public Announcement

According to the relevant provisions of the "Interim Measures for Public Participation in Environmental Impact Assessment," combined with the characteristics of the construction project

2015-10-06

2015 company employee training

From September 29th to 30th, 2015, the company took pictures after training all employees on safety, GMP, ICQ7, TPM and corporate culture.

2015-01-23

Chongqing Huafang Wulingshan Pharmaceutical Co., Ltd. Enterprise Technology Center

Chongqing Huafang Wulingshan Pharmaceutical Co., Ltd. is recognized as a municipal enterprise technology center

2015-01-22

High-tech products

Artemisinin, artemether, dihydroartemisinin, artesunate